Učitavanje...
Cardiometabolic Outcomes and Mortality in Medically Treated Primary Aldosteronism: A Retrospective Cohort Study
BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) are the recommended medical therapy for primary aldosteronism (PA). Whether this recommendation effectively reduces cardiovascular risk is not well understood. METHODS: We conducted a cohort study including 602 PA patients treated with MRAs a...
Spremljeno u:
| Izdano u: | Lancet Diabetes Endocrinol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5953512/ https://ncbi.nlm.nih.gov/pubmed/29129576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-8587(17)30367-4 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|